Call Options

33 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $5.87 Million - $6.65 Million
-211,900 Reduced 26.53%
586,900 $17 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $7.37 Million - $8.63 Million
291,700 Added 57.52%
798,800 $22.4 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $22 Million - $25.2 Million
-848,000 Reduced 62.58%
507,100 $14.1 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $11 Million - $14.2 Million
419,800 Added 44.88%
1,355,100 $39 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $20.4 Million - $23.8 Million
-635,500 Reduced 40.46%
935,300 $31 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $29.7 Million - $34.3 Million
821,400 Added 109.61%
1,570,800 $57.6 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $75.2 Million - $97.9 Million
-1,909,800 Reduced 71.82%
749,400 $30.6 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $53.9 Million - $70.4 Million
1,291,700 Added 94.46%
2,659,200 $136 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $45.1 Million - $55 Million
-1,029,600 Reduced 42.95%
1,367,500 $59.8 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $47.4 Million - $56.2 Million
1,019,300 Added 73.98%
2,397,100 $126 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $63 Million - $78.1 Million
1,377,800 New
1,377,800 $71.3 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $120 Million - $178 Million
-2,902,500 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $10 Million - $14.9 Million
243,000 Added 9.14%
2,902,500 $171 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $104 Million - $134 Million
2,659,500 New
2,659,500 $114 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $83.5 Million - $107 Million
-2,126,200 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $76.4 Million - $86.5 Million
2,126,200 New
2,126,200 $83.3 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $70 Million - $78.9 Million
-2,089,300 Reduced 49.65%
2,118,400 $76.7 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $70.9 Million - $80 Million
-2,118,400 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $141 Million - $179 Million
4,207,700 New
4,207,700 $155 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $148 Million - $188 Million
-4,427,900 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $56.3 Million - $66.1 Million
1,774,800 Added 66.9%
4,427,900 $163 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $28 Million - $33.9 Million
928,700 Added 53.86%
2,653,100 $86.8 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $3.42 Million - $4.89 Million
-126,600 Reduced 6.84%
1,724,400 $56.3 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $4.06 Million - $4.61 Million
-123,400 Reduced 6.25%
1,851,000 $72.5 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $13.1 Million - $16.9 Million
401,900 Added 25.56%
1,974,400 $67.3 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $6.71 Million - $7.54 Million
-181,500 Reduced 10.35%
1,572,500 $68.1 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $40.2 Million - $44.2 Million
1,072,400 Added 157.34%
1,754,000 $74.5 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $5.51 Million - $6.29 Million
143,300 Added 26.62%
681,600 $29.8 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $6.21 Million - $7.53 Million
180,200 Added 50.32%
538,300 $23.7 Million
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $7.67 Million - $8.18 Million
232,700 Added 185.57%
358,100 $13 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $14.7 Million - $17 Million
-460,300 Reduced 78.59%
125,400 $4.45 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $21.5 Million - $22.9 Million
-647,600 Reduced 52.51%
585,700 $21.2 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $38.2 Million - $42.1 Million
1,233,300
1,233,300 $44 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.